| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 02:14:10 UTC |
|---|
| Update Date | 2021-09-26 22:59:16 UTC |
|---|
| HMDB ID | HMDB0248788 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
|---|
| Description | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid belongs to the class of organic compounds known as pyrazinecarboxamides. Pyrazinecarboxamides are compounds containing a pyrazine ring which bears a carboxamide. Based on a literature review very few articles have been published on {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). {4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1=NC(C)=C(N=C1C(N)=O)C1=CC=C(C=C1)C1CCC(CC(O)=O)CC1 InChI=1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26) |
|---|
| Synonyms | | Value | Source |
|---|
| {4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetate | Generator |
|
|---|
| Chemical Formula | C21H25N3O3 |
|---|
| Average Molecular Weight | 367.449 |
|---|
| Monoisotopic Molecular Weight | 367.189591677 |
|---|
| IUPAC Name | 2-{4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
|---|
| Traditional Name | {4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=NC(C)=C(N=C1C(N)=O)C1=CC=C(C=C1)C1CCC(CC(O)=O)CC1 |
|---|
| InChI Identifier | InChI=1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26) |
|---|
| InChI Key | YXFNPRHZMOGREC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyrazinecarboxamides. Pyrazinecarboxamides are compounds containing a pyrazine ring which bears a carboxamide. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyrazines |
|---|
| Direct Parent | Pyrazinecarboxamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyrazinecarboxamide
- 2-heteroaryl carboxamide
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Carboxamide group
- Primary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.2265 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.16 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1718.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 203.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 184.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 221.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 399.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 388.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 429.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 939.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 410.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1223.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 340.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 322.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 280.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 320.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 3397.8 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 3212.4 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C | 4192.5 | Standard polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3563.7 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3399.9 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 4256.1 | Standard polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3476.3 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3403.8 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C)[Si](C)(C)C | 3941.3 | Standard polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 3811.2 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 3645.1 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N[Si](C)(C)C(C)(C)C | 4295.3 | Standard polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3996.0 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3773.0 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,2TBDMS,isomer #2 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4300.4 | Standard polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4029.1 | Semi standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3958.3 | Standard non polar | 33892256 | | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid,3TBDMS,isomer #1 | CC1=NC(C)=C(C2=CC=C(C3CCC(CC(=O)O[Si](C)(C)C(C)(C)C)CC3)C=C2)N=C1C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4087.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-066s-1197000000-7172125dc11bdf65b20e | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 10V, Positive-QTOF | splash10-0gb9-0009000000-3feddcd76d79b3765cb4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 20V, Positive-QTOF | splash10-0udi-0049000000-d281229b72c47b74925d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 40V, Positive-QTOF | splash10-0pxr-0094000000-1392fae5889379dd174d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 10V, Negative-QTOF | splash10-014i-0009000000-19efc1e763672b76b04e | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 20V, Negative-QTOF | splash10-0096-6039000000-0465d331e0e7901219ae | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid 40V, Negative-QTOF | splash10-0006-9074000000-fac3feccd5fe60c02a55 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|